SUMMARY Acquisition of resistance to neomycin, gentamicin, fusidic acid, or clindamycin has been observed in three strains of Staphylococcus aureus and data from three patients infected with these strains are presented in detail. Clindamycin resistance followed the expected pattern by appearing in a strain of Staph. aureus with dissociated resistance to erythromycin after treatment with erythromycin and clindamycin. Low-level resistance to fusidic acid appeared in two strains in the apparent absence of exposure to that antibiotic. Labile neomycin resistance was encountered in a previously sensitive strain after topical neomycin therapy. Gentamicin resistance appeared in all three strains after topical therapy. In all three strains, a labile resistance (presumably plasmid-mediated) occurred with minimum inhibitory concentrations (MICs) of 64-128 ,ug/ml but in one strain a stable resistance with MIC over 3000 ,ug/ml appeared.
Staphylococcus aureus infection in skin wards has been studied and reported previously (Wilson et al., 1971; Noble and White, 1972) . The large number of highly resistant staphylococci in such wards is more than probably due to the extensive use of topical and systemic antibiotics. Ayliffe et al. (1977) also surveyed staphylococcal carriage in dermatology and burns wards and found a high incidence of multiple antibiotic-resistant strains of Staph. aureus in both environments.
Multiple antibiotic-resistance in staphylococci is thought to arise from the acquisition of separate resistance genes (Dyke et al., 1970) . Neomycin and fusidic acid resistances are usually plasmid-mediated (Lacey, 1971; Lacey and Grinsted, 1972) . Gentamicin resistance has until recently been rare in staphylococci, but there is now an increasing number of outbreaks (Porthouse et al., 1976; Shanson et al., 1976; Speller et al., 1976; Bint et al., 1977) . In those strains that have been well documented the resistance has been plasmid-mediated (Soussey et al., 1975; Wood et al., 1977; Wyatt et al., 1977) . Clindamycin resistance normally occurs in strains already having erythromycin resistance of the dissociated type, reported by Garrod (1957) .
In this study we describe gain of resistance to neomycin, fusidic acid, gentamicin, and clindamycin by three strains of Staph. aureus isolated from skin patients undergoing antibiotic and other therapy. The study is illustrated by reference to specific case Received for publication 5 June 1978 histories and describes the nature of the genes' mediating resistance. Strain I was not typable at RTD or RTD x 100 after growth of the cultures at 37 C or 42 C. Culture supernatants and mitomycin-C induced cultures yielded phages that lysed the Staph. aureus propagating strains PS6, PS47, PS75, PS77, and PS83A (Table 1 ). The induced phages were also lytic on the 77/84/90 strain discussed below.
Material and methods

Strains
Fucidin and gentamicin Mrs B was infected with two distinct strains of Staph. aureus during her stay in hoIspital. Strain 2 was isolated from swabs taken on the day of admission (Fig. 1) . The patient had been using neomycin ointment before admission. Strain 2 still persisted after erythromycin (250 mg four times daily for nine days), tetracycline (mouth wash), and cloxacillin (500 mg four times daily for 11 days) treatment. Fusidic acid resistance determined by disc test appeared after cloxacillin but before fucidin treatment (500 mg four times daily for six days); genta- NT = not typable at RTD and RTD x 100 after incubation at 37°or 42 C P = penicillin, T = tetracycline, N = neomycin, E = dissociated resistance to erythromycin, M methicillin, S = high level streptomycin, and G = gentamicin. micin resistance appeared very soon after topical and systemic gentamicin treatment had been started. Superinfection with the strain 1 described earlier occurred when the patient received cloxacillin (Fig. 2). As with strain 2, fusidic acid resistance appeared before treatment with the antibiotic. Again, soon after gentamicin therapy had been started, isolates resistant to gentamicin were recovered.
The NT strain was indistinguishable from that in- Gentamicin MICs for strains 1, 2, and 3 are given in Table 3 . In strain 3 there were two markedly different levels of gentamicin resistance. The isolates R/PG and R/PNG exhibited the extremely high-level resistance; only the R/PTG isolates had the lower MIC. The MICs of strains 1 and 2 were more difficult to determine accurately and tended to fluctuate between 64 and 128 tzg/ml. This was probably due to inconsistent plasmid loss during growth of the culture (see below).
All strains acquiring resistance to gentamicin were cross-resistant to kanamycin and tobramycin. However, the high MIC isolates of strain 3 were, in addition, resistant to amikacin. It must be noted here that both the R/PG and R/PTG isolates of this Table 4 . In each case a proportion of the sensitive variants were phage-typed and found to be the same as the parents. Loss of erythromycin resistance could not be demonstrated in the 2077 isolates of strain I tested. Fusidic acid resistances in both strains 1 and 2 were also stable and no sensitive variants have yet been obtained. The gentamicin resistances in these two strains, however, were extremely labile. Both cultures spontaneously gave rise to a high proportion of gentamicin-sensitive variants. Single colonies from gentamicin agar were also found to yield about 50% sensitive cells. In strain 3 the neomycin resistance was unstable; gentamicin resistance could be lost from the R/PTG isolate but not from any of the high MIC isolates. Loss of gentamicin resistance could also be demonstrated in the Staph. epidermidis strain from Mrs B. Loss of kanamycin resistance accompanied loss of gentamicin resistance in strains 1, 2, and 3.
Discussion
The evolution of plasmids in Staph. aureus and the clinical importance of antibiotic resistance has been reviewed by Lacey (1975) and the specific role of the skin by Noble and Naidoo (1978) . This study illustrates gain in resistance to clindamycin, fusidic acid, neomycin, and gentamicin in vivo in three clinical strains of Staph. aureus previously sensitive to the antibiotics. Appearance of resistance in each instance (except fusidic acid resistance) was coincident with the therapeutic use of antibiotics, topically applied in the case of neomycin and gentamicin.
The NT strain infecting Mrs B and Miss C was initially resistant to penicillin, tetracycline, erythromycin, methicillin, and streptomycin. The appearance of clindamycin resistance in this strain was typical of exposure of a strain with dissociated erythromycin resistance to erythromycin and then clindamycin (Weisblum et al., 1971) .
Strains 1 and 2 acquired gentamicin resistance apparently simultaneously on one patient. The gentamicin-resistant isolate of strain 1 was sensitive to fusidic acid while that of strain 2 was resistant to fusidic acid, indicating that the two resistances were acquired independently. The gentamicin resistances in both strains were extremely labile and therefore probably plasmid-mediated. No linkage was observed with any of the other resistances. Fusidic acid resistance was stable in both strains and may be chromosomal; in any case it was of a very low level. MICs of the resistant and sensitive cultures of each strain were: 4 ,ug/ml and < 01 ,Iug/ml (NT), 8 ,tg/ml and 0-8 pg/ml (77/84/90). There was no association of fusidic acid resistance with the penicillinase plasmid, that is, resistance to penicillin in strain 77/84/90 could be lost independently of fusidic acid resistance (Lacey and Grinsted, 1972 (Lacey and Richmond, 1974) and may well have occurred naturally between strains 1 and 2 infecting Mrs B since transfer between these strains occurs on skin under experimental conditions . But from where did these Staph. aureus strains acquire the plasmid? Lacey (1975) (Witte, 1977) . The high incidence of gentamicin-resistant Staph. epidermidis and Staph. aureus which we have isolated simultaneously from patients strongly supports the idea that plasmid transfer between these species may occur in vivo.
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